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Available online 29 May 2016AbstractObjective: The aim of this study is to perform a comprehensive evaluation of 5 years of experience with the technique of isolated pancreatic
anastomosis reconstruction after pancreatoduodenectomy from the perspective of safety and surgical efficacy using a prospective database.
Methods: The study included all consecutive patients undergoing pancreatoduodenectomy from April 2009 to April 2014 at a single referral
center for hepato-pancreato-biliary diseases. The primary endpoint was the safety of the procedures, which was assessed as the occurrence
of complications during hospitalization. Ninety-day mortality was also assessed. Postoperative pancreatic fistulas were classified as grade
A, B, or C according to the International Study Group of Pancreatic Fistula classification.
Results: The study group included 214 consecutive patients with a median age of 60 years who underwent pancreatoduodenectomy. Portal
vein resection was performed on 41 patients. Indications for resection were 165 pancreatic head tumors, 33 ampullary tumors, 7 chronic
pancreatitis, 3 distal bile duct tumors, and 6 duodenal tumors. There was no perioperative or 90-day mortality in this series. Complications
occurred in 68 patients (32%), and 42 patients presented with pancreatic fistulas (19.6%). Grade A fistulas were present in 38 patients.
Three patients presented persistent pancreatic fistula and were treated with percutaneous drainage. One patient developed combined pancre-
atic and biliary fistulas and was reoperated on for pancreatic abscess drainage.
Conclusions: The technique of isolated pancreatic anastomosis by diverting the pancreatic from biliary secretion may contribute to reducing
the severity of pancreatic fistulas and therefore the severity of this complication.
 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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5,6Introduction
Pancreatoduodenectomy (PD) is an established proce-
dure for the treatment of benign and malignant diseases
located at the pancreatic head and periampullary region.
Although many techniques have been devised to reduce
the rate of postoperative complications after PD, postoper-
ative morbidity remains a major concern. The morbidity
rate is 40e50% of patients, even in highly specialized cen-
ters.1e3 The most important postoperative complication is
pancreatic fistula.3,4 Perioperative complications are even
higher in low-volume centers, and mortality is a serioushor. Rua Dona Adma Jafet 74 cj 102, 01308-050 S~ao
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).problem. Most of the complications after PD are related
to pancreatic fistulas. Many strategies have been developed
to reduce these complications, such as the use of octreotide,
duct stents, and many other techniques for reconstruction of
the alimentary tract.7e15
In some patients, the outcome of pancreatic fistula is
benign, whereas other patients may have an extremely se-
vere or even fatal outcome after developing postoperative
pancreatic fistulas. The actual mechanism for this differ-
ence in outcomes may be the activation of pancreatic juice
by biliary secretion. In order to decrease morbidity and
mortality rates after PD, we devised a unique technique us-
ing two different jejunal loops for hepatico- and pancrea-
tico-jejunostomy.11 This technique has significantly
decreased the severity of complications for our patients.
Several modifications of the technique that maintain thecess article under the CC BY-NC-ND license (http://creativecommons.org/
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confirmed our initial results.12e17
The aim with this study is to perform a comprehensive
evaluation of 5 years of experience with this technique
from the perspectives of safety and surgical efficacy using
a prospective database. The study is also aimed at providing
a technical description of isolated pancreatic anastomosis
reconstruction.
MethodsStudy design and settingThis observational study analyzed a cohort of patients at
an urban referral center for HPB surgery in S~ao Paulo,
Brazil. All patients undergoing pancreatic resection at
our institution were recorded in a database, which is pro-
spectively maintained by our HPB fellows and clinical
study nurses and is presented to a multidisciplinary tumor
board. High-quality CT scans and/or MRI preoperative im-
aging is routinely performed. Coronal and sagittal views
are essential for evaluating vascular encasement. If
involvement less than 180 of the superior mesenteric ar-
tery or short segment hepatic artery involvement at the
gastroduodenal artery (GDA) or short segment involve-
ment of the portal vein (<3 cm) is found, the patient is
considered borderline Katz type A according to the classi-
fication proposed by the MD Anderson group.18 These pa-
tients are referred for neoadjuvant chemotherapy and
reevaluation. Portal involvement is considered a contrain-
dication for surgery if the SMV-portal axis is occluded
for more than 3 cm or there is not patent SMVor PV above
and below the occlusion. These patients as well as those
with intravascular tumoral thrombus are considered nonre-
sectable and are referred for radiochemotherapy, although
with a surgical reevaluation of the status of the PV-SMV
axis.
Consecutive patients undergoing open pancreatoduode-
nectomy by this team in the 5-year period between April
2009 and April 2014 were retrospectively studied. One of
the two authors was the senior surgeon in all procedures.
Patients with intraoperative diagnosis of liver metastases
or peritoneal implants were excluded from the analysis
(Fig. 1).Surgical techniqueThe operation starts with a complete exploration of the
abdominal cavity to rule out peritoneal and/or liver metas-
tasis. Pancreatic dissection is performed after opening the
retrocavity and performing the Kocher maneuver. After di-
vision of the gastroepiploic vessels, the duodenum is trans-
ected 2 cm below the pylorus with linear stapler. All
patients except for 6 cases of duodenal cancer underwent
pylorus-preserving pancreatoduodenectomy. In those 6
cases, distal gastrectomy was performed and reconstructionwas done in the same way, but with gastrojejunal anasto-
mosis instead. Cholecystectomy is performed, and the com-
mon bile duct is dissected and divided.
The hepatoduodenal ligament is skeletonized, the
gastroduodenal artery is divided, and the portal vein is
exposed above the pancreas. A tunnel is carefully created
behind the neck of the pancreas, and the pancreas is
divided. The jejunum is divided with a stapler 20 cm distal
to the Treitz ligament. Finally, the uncinate process is care-
fully dissected from the superior mesenteric vein and the
artery, and PD is completed. In cases with known involve-
ment of the portal vein, pancreatic resection begins with su-
perior mesenteric artery dissection, technique that was
previously described by our group19 and subsequently
popularized under the name “artery-first technique”.20
Another indication for performing artery-first dissection is
the presence of a displaced common or right hepatic artery
from the superior mesenteric trunk.
After pancreatic head resection, a double-layered retro-
colic end-to-side pancreaticojejunostomy is performed
with duct-to-mucosa anastomosis using running monofila-
ment sutures and a second layer between the jejunal sero-
muscular and pancreatic tissue to reinforce the
anastomosis. In smaller ducts, interrupted sutures are
used. Pancreatic stents are used in soft glands or in ducts
smaller than 3 mm.
Next step is to create a Roux-en-Y limb using a single
stapler firing, as previously reported.21 A 40-cm jejunal
loop is left for the biliary reconstruction (Fig. 2). This
biliary loop is brought through another opening in the mes-
ocolon for use in biliary reconstruction. Hepaticojejunos-
tomy is usually performed with end-to-side running 5-
0 PDS suture. Finally, an end-to-side duodenojejunal anas-
tomosis is performed 30 cm downstream from the Roux-en-
Y using the standard double-layer technique in an antecolic
fashion (Fig. 2). Abdominal cavity drainage is also done
separately. Two drains are used and exteriorized on either
side of abdominal cavity.VariablesThe primary endpoint of this study is the safety of this
procedure, which was assessed as the occurrence of compli-
cations during hospitalization (Dindo-Clavien classifica-
tion) as well a 90-day mortality. Postoperative pancreatic
fistulas were classified as grade A, B, or C according to
the International Study Group of Pancreatic Fistula classifi-
cation.22 The recently published comprehensive complica-
tion index (CCI) to explore a different system for severity
of complications.23 Secondary outcomes were surgical effi-
cacy endpoints such as conversion rates, operative times,
blood loss, need for transfusions, proportion of positive
margins, and hospital length of stay.
Figure 1. Flow diagram showing all referred patients for pancreatoduodenectomy in our institution between 2009 and 2014 and stratified by resectability and
type of operation. CT e chemotherapy.
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As in any retrospective cohort study, it identified an era
and selection bias that may have contributed to a better
outcome.Figure 2. Schematic drawing of isolated pancreatic anastomosis technique
for reconstruction of the alimentary tract after pancreatoduodenectomy.
Roux-en-Y limb is created. One jejunal loop (40 cm) is brought through
the mesenteric window for pancreatic anastomosis, and another loop
(40 cm) in another window is used for biliary reconstruction. Distal
jejunum is used for duodenojejunal anastomosis in an antecolic fashion
performed 30 cm downstream from the Roux-en-Y.ParticipantsThe study group included 214 patients with a median
age of 60 years (range: 20e83 years) who underwent pan-
creatoduodenectomy. Patient demographics and preopera-
tive parameters are depicted in Table 1. Indications for
resection were 165 pancreatic head tumors, 33 ampullary
tumors, 7 chronic pancreatitis, 3 distal bile duct tumors,
and 6 duodenal tumors (Table 2). TNM stage was depicted
in Table 3. Among all patients referred for surgery, 19 were
found resectable after neoadjuvant chemotherapy and 13
were not resected after intraoperative findings of irresect-
ability (Fig. 1). Four patients presented peritoneal implantsTable 1
Patient demographics and comorbidities.
Demographics and preoperative parameters
Age, median (range), y 60 (20e83)
Gender, Male:Female, n 118:96
Jaundice, n (%) 143 (67)
Weight loss, n (%) 81 (37.8)
Albumin <3.5 g/dL, n (%) 41 (19.1)
Weight loss > 10%, n (%) 32 (14.9)
BMI, mean  SD, kg/m2 26.2  2.2
Malnutritiona, n (%) 14 (6.5)
Hypertension, n (%) 65 (30.4)
Diabetes, n (%) 48 (22.4)
Smoking, n (%) 92 (43)
Alcohol abuse, n (%) 30 (14)
Prior abdominal surgery, n (%) 43 (20)
Preoperative biliary drainage, n (%) 18 (8.4)
a Weight loss >10% with albumin <3 or BMI < 20.
Table 2
Pathology and TNM stage.
n %
Pathology
Pancreatic adenocarcinoma 165 77.1
Periampullary adenocarcinoma 33 15.4
Chronic pancreatitis 7 3.2
Duodenal adenocarcinoma 6 2.8
Distal bile duct cancer 3 1.4
TNM stagea
Stage 0 1 0.5
Stage IA 5 2.4
Stage IB 21 10.1
Stage IIA 70 33.8
Stage IIB 97 46.9
Stage III 13 6.3
7 patients with chronic pancreatitis were excluded.
a 7th Edition American Joint Committee on Cancer (AJCC) TNM
staging.
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abdominal inspection.
Pylorus preservation was possible in 208 patients (97%).
In six patients with duodenal cancer, distal gastrectomy was
necessary, and standard pancreatoduodenectomy was per-
formed. Portal vein resection was performed in 41 patients
(19%), which consisted of lateral venorrhaphy in 25 pa-
tients and end-to-end portal reconstruction in the remaining
patients (Table 3).OutcomesOperative variables and outcomes are summarized in
Table 3. There was no perioperative or 90-day mortalityTable 3
Operative variables and complications.
Variable n
Operative time, mean  SD, min 243  120
Estimated blood loss, mean  SD, mL 384  215
Pylorus-preserving pancreatoduodenectomy, n (%) 208 (97)
Standard pancreatoduodenectomy, n (%) 6 (3)
Portal vein resection, n (%) 41 (19)
Blood transfusion during hospitalization, n (%) 52 (24.3)
Use of pancreatic stent, n (%) 61 (28.5)
ICU stay, mean  SD, d 2.2  1.2
Hospital stay, mean  SD, d 9.7  4.1
Overall Complications, n (%) 68 (32)
Complications  IIIA (Clavien-Dindo), n (%) 10 (4.7)
CCI, median (range) 23.5 (0e42.4)
Pancreatic fistula, n (%) 42 (19.6)
Grade A 38
Grade B 3
Grade C 1
Wound infections, n (%) 8 (3.8)
Delayed gastric emptying, n (%) 6 (2.8)
Cardio-pulmonary complications, n (%) 6 (2.8)
Bile leak, n (%) 2 (1)
Post-pancreatectomy bleeding, n (%) 2 (1)
Reoperation, n (%) 2 (1)
Mortality 0
SD ¼ standard deviation, CCI ¼ comprehensive complications index.in this series. Complications occurred in 68 patients
(32%), while 42 patients presented with pancreatic fistula.
Grade A fistulas were present in 38 patients (90%). Three
patients presented persistent pancreatic fistula (7%) and
were treated with percutaneous drainage (grade B). One pa-
tient developed a combined pancreatic and biliary fistula
and was reoperated on for pancreatic abscess drainage
(grade C e 3%). Two other patients were reoperated due
to internal hernia with obstruction and bowel ischemia.
One patient developed gastroduodenal artery pseudoaneur-
ysm, which was treated by endovascular prosthesis. Six pa-
tients presented delayed gastric emptying. All of these
patients recovered uneventfully. One patient developed
biliary stenosis that required reoperation 6 months after
pancreatic resection after failure of percutaneous dilatation.
Discussion
Despite recent advances in surgical procedures and post-
operative management techniques, pancreatoduodenectomy
still carries a considerable postoperative morbidity and
mortality. The mortality rate is likely higher in low volume
hospitals.5,25 Highly specialized medicine in high volume
centers seems to be the key to provide a better outcome
for these patients, but it has been implemented only in a
few highly developed countries.26,27 The present data are
from highly experienced pancreatic surgeons in a high-
volume institution (with a mean of 45 Whipple procedures
per year) from a developing country. Similar to other expe-
riences the mortality rate in our department was around
40% in the 1970s,11 leading some authors to suggest that
its use be abandoned.28,29 At this time the simple change
in the technique with the systematic use of an isolated
pancreatic anastomosis resulted in a sharp decrease in the
postoperative mortality to 5%.30 Later on, Funovics
et al.31 in an analysis of three different techniques for
reconstruction after pancreatoduodenectomy concluded
that the use of separate intestinal loops offers the best tech-
nical solution to the morbidity of this operation.
Since them, several other techniques and advances in the
surgical field resulted in a rapid decline in the mortality rate
worldwide. However, pancreatic fistula is still the most
common factor responsible for the high morbidity and mor-
tality after pancreatoduodenectomy.32 To reduce the inci-
dence and complications of this anastomosis, several
techniques have been used, such as pancreaticogastrostomy,
duct-to-mucosa anastomosis, binding pancreatojejunos-
tomy, perioperative administration of somatostatin analogs,
and the use of adhesive sealants, among others. However,
no advantages have been shown of one technique over
another.1
Variations of pancreatojejunostomy have been evaluated,
and lower pancreatic fistulas rate were see in the invagination
technique, especially in the soft pancreas.33 In other studies,
superiority was demonstrated for duct-to-mucosa anasto-
mosis.34 Other variations of pancreatic reconstruction have
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tomy, pancreatogastrostomy does not show any significant
differences in the overall postoperative complication rate or
incidence of pancreatic fistula.9,10 Since a reliable technique
for pancreatojejunostomy has not been devised, additional
managements have been used to decrease the incidence or
severity of pancreatic fistulas. In some studies, external
drainage of the pancreatic duct with a stent reduced the rate
of pancreatic fistula after pancreaticojejunostomy, mainly in
patients with soft glands.20,36
Most of the reports related to pancreatic fistula were per-
formed without a standardized definition of pancreatic fistula
and its newly introduced grading system and focused
decreasing the incidence and not to the severity of the compli-
cation.17 Pancreatic juice is secreted in an inactivated state
and is activated in the bowel lumen by mainly biliary secre-
tion. In the event of a pancreatic fistula in a patientwith an iso-
lated pancreatic anastomosis, the leak will consist of inactive
pancreatic enzyme precursors that are not associated with
serious complications.37,38 An important and sometimes ne-
glected is the adequate length (40 cm) of the jejunal loop.
We found however that another essential point is placing
two separated drains to isolate the drainage fluids from the
rest of the operative field, one adjacent to the pancreatic stump
and another near the biliary anastomosis. Biliary pancreatic
secretion activation is in our opinion the main factor respon-
sible for the severity of pancreatic fistula. We induced this
from the simple observation that postoperative mortality is
extremely high in patients with combined biliary and pancre-
atic fistulas after pancreatoduodenectomy.39We presume that
the use of a single jejunal loop for biliary and pancreatic anas-
tomosis leads to the activation of proteolytic enzymes and
consequent tissue damage. Separation of the biliary and
pancreatic conduits may decrease the severity of pancreatic
fistulas,11,13,14 therefore reducing themorbidity andmortality
of pancreatoduodenectomy. This was the rationale behind the
double jejunal loop technique first description in 1976. The
morbidity remained 60% with 50% of pancreatic complica-
tions but the mortality decreased from 40 to 5% at the
time.30 This assumption was then demonstrated by Ke
et al.17 Their prospective randomized study showed that iso-
lated pancreatic anastomosis was not associated with a lower
incidence of pancreatic fistula in comparison with conven-
tional reconstruction but it contributed to decreasing fistula
severity, duration of stay, and hospital expense.17We are sup-
porting the findings of this randomized studywith our clinical
audit of a consecutive series of 214 patients to show that the
majority of patients in the present series who developed
pancreatic fistula had a grade A pancreatic fistula.
Additional benefits of isolated pancreatic anastomosis
are the prevention of chronic biliary duct damage from
pancreatic juice reflux, which may cause epithelial erosion
dysplasia and cholangiocarcinoma.40 This may be impor-
tant for young patients operated on for benign or low-
grade malignancy with expected long-term survival.
Although there is no evidence of this hypothetical risk,there are single case reports of “de novo” cholangiocarci-
noma after pancreatoduodenectomy for distal bile duct can-
cer.41,42 Another advantage of this type of alimentary
reconstruction is related to the eventual need for reopera-
tion for biliary or pancreatic anastomosis complications,
such as stenosis.41 Reoperation in this setting may be easier
and safer when separate loops have been used.
One point of criticism is that the use of this technique is
time-consuming. This may be overcome with the use of the
single-firing stapler technique.21 We are aware that the iso-
lated pancreatic anastomosis technique may be undervalued
by some high volume centers.40 We suggest however this
technique may further reduce complications even in these
high-volume centers. Certainly our technique appears useful
in situations where high morbidity and mortality are ex-
pected after pancreatoduodenectomy. The typical situation
to utilize this technique is when the pancreas is soft and the
pancreatic duct is small. Another typical situation arises
whenWhipple procedures are performed in low-volume cen-
ters or by inexperienced surgeons.43e45 In both scenarios this
technique that may decrease morbidity and mortality despite
the fact that we recommend referral to high volume centers.
Due to the success with this technique we utilize this
type of reconstruction also been used in our laparoscopic
pancreaticoduedenectomies with similarly satisfying re-
sults.44 Other surgical center have had no mortality or no
pancreatic complications in their consecutive series of pan-
creatoduodenectomy.45e50 According to Samra et al.,49 a
multidisciplinary team was the key to avoiding mortality,
even after 19% of severe postoperative complications.
Even in middle-volume centers, it is possible to have
zero-mortality after PD.50 In the Johns-Hopkins experience
with 650 patients, operative mortality was 1.4%, but they
also reported a consecutive series of 190 patients without
mortality was seen during the period of study. Pancreatic
fistula occurred in 14% of patients.48 One study by Sutton
et al. using isolated pancreatojejunostomy achieved a
pancreatic leak rate of zero.45 Of course good outcomes af-
ter the Whipple procedure are indeed multifactorial and are
certainly never cause by a single surgical technique. The
multidisciplinary approach, high volume and standardiza-
tion of the technique contributed also to improve outcome
in our series over time. Our objective is not to keep zero
mortality since may well not be realistic for a long period
as already published.48
The current study has several limitations, in particular, the
retrospective nature of the study and a potential era bias.
Additionally all patients were treated in a high-volume center
after evaluation by a multidisciplinary team, which may well
introduce a selection bias. Despite this, we found the clinical
audit helpful to evaluate out subjective impression that out-
comes had improved after we introduced the standard use
of the isolated pancreatic anastomotic technique.
In conclusion, our retrospective clinical audit shows that
while our cohort is comparable to series of pancreatico-
duodenectomies in the published literature, our
1589M.C.C. Machado, M.A.C. Machado / EJSO 42 (2016) 1584e1590complication and mortality rates are comparatively low and
the severity of postoperative pancreatic fistulas are fairly
mild. The isolated pancreatic anastomosis technique by di-
verting the pancreatic from biliary secretion may contribute
to reducing the severity of pancreatic fistula and the
dangerous sequelae of this complication.
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